Treatment of Secondary Hyperparathyroidism in the Uremic Patient

NCT00469599 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

86

Enrollment

OTHER

Sponsor class

Stopped Terminated after 86 pt included, because of recruitment problems

Conditions

Secondary Hyperparathyroidism
Chronic Kidney Disease
Vitamin D Deficiency

Interventions

DRUG: paricalcitol
DRUG: alfacalcidol

Sponsor

Zealand University Hospital